|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 405/06 | |
| C07D 405/06 | |||
| C07D 307/00 | |||
| C07D 213/00 |
| (11) | Number of the document | 1701953 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05705212.8 |
| Date of filing the European patent application | 2005-01-07 | |
| (97) | Date of publication of the European application | 2006-09-20 |
| (45) | Date of publication and mention of the grant of the patent | 2014-11-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2005/000447 |
| Date | 2005-01-07 |
| (87) | Number | WO 2005/070923 |
| Date | 2005-08-04 |
| (30) | Number | Date | Country code |
| 755066 | 2004-01-09 | US |
| (72) |
THIRUVENGADAM, Tiruvettipuram, K., US
WU, Wenxue, US
WANG, Tao, US
CHIU, John, S., US
BOGDANOWICH-KNIPP, Susan, US
PAVLOVSKY, Anastasia, US
GREENLEE, William, J., US
GRAZIANO, Michael, P., US
KOSOGLOU, Teddy, US
CHINTALA, Madhu, US
CHACKALAMANNIL, Samuel, US
|
| (73) |
Merck Sharp & Dohme Corp.,
126 East Lincoln Avenue, Rahway, NJ 07065-0907,
US
|
| (54) | Process for the production of a crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist |
| Process for the production of a crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist |